Liam Ratcliffe is the Head of Biotechnology at Access Industries, a privately-held multi industry investment group based in New York that invests in private and public companies.  Liam leads Access Biotechnology investment strategy, a strategy which is broad, long term and aims to enable innovative therapeutic platforms and products across three key stages: company foundation; technology translation and company expansion.  Prior to leading life sciences at Access Industries, Liam was a Managing Director at New Leaf Venture Partners, and concentrated on biopharmaceutical investing. Liam joined New Leaf in September 2008. Liam previously served as Senior Vice President and Development Head for Pfizer Neuroscience, as well as Worldwide Head of Clinical Research and Development. He worked for Pfizer for a total of 12 years.

Liam began his career in the pharmaceutical industry in a medical marketing role at Roche in South Africa. He received his medical degree and Ph.D. degree in immunology from the University of Cape Town and his M.B.A. degree from the University of Michigan.